ASAda Cleary Sher

Ada Cleary Sher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ada Cleary Sher has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Tendy Chiang

    Center for Regenerative Medicine Abigail Wexner Research Institute, Nationwide Children's Hospital Columbus Ohio USA

    3 shared publications
  • Lumei Liu

    Center of Regenerative Medicine, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH, USA

    2 shared publications
  • Amy Manning

    Department of Pediatric Otolaryngology Nationwide Children's Hospital Columbus Ohio USA

    1 shared publication
  • Audrey Miller

    Department of Pediatrics, Division of Neonatology Nationwide Children's Hospital Columbus Ohio USA

    1 shared publication
  • Hajera Afreen

    The Ohio State University College of Medicine Columbus Ohio USA

    1 shared publication
  • Humra Shamim

    Center for Regenerative Medicine, Abigail Wexner Research Institute Nationwide Children's Hospital Columbus Ohio USA

    1 shared publication

Latest Publications

  • Surgery-Induced Stress Promotes SOX9 Nuclear Localization and Increases COL2A1 in Tracheal Cartilage

    by Sovannarath Pong, Lumei Liu, Jazmin Calyeca, Ada C. Sher, Sarah Sussman, Tendy Chiang

    Objective: Airway reconstruction triggers a surgery-induced stress (SIS) response, but its effect on cartilage regeneration remains elusive. SOX9 regulates cartilage regeneration by promoting type II collagen production and may aid in repair; however, the role of SOX9 in response to SIS is unclear. We utilized a mouse model to validate SOX9 nuclear expression in tracheal chondrocytes and assess its localization after segmental tracheal replacement. Methods: Tracheas from C57BL/6J mice were digested using Dispase-Collagenase-Trypsin, then collagenase II to isolate chondrocytes for primary culture. Syngeneic tracheal grafts were harvested from donor animals, and a 3 to 4 mm tracheal graft was implanted orthotopically to assess chondrocyte function in vivo. At 1 month, graft, anastomosis, and adjacent host tissues were harvested. Samples were stained for SOX9 and COL2A1, and their localization was analyzed with ImageJ. Results: Primary tracheal chondrocytes showed strong nuclear SOX9 and cytoplasmic COL2A1 expression. One month after orthotopic tracheal replacement, SOX9 nuclear colocalization increased in the host and anastomosis regions ( P = .0269 and P = .0262, respectively), but not in the graft ( P = .5958). COL2A1 intensity in the cartilage matrix was significantly higher in graft, host, and anastomosis compared to native cartilage (all P < .01), with no morphological differences. Conclusion: After tracheal reconstruction, increased SOX9 and COL2A1 intensities indicate a potential chondrocyte response to SIS. SOX9 nuclear localization may be involved in regulating COL2A1 in tracheal chondrocytes during cartilage injury and repair. This supports a possible role for SOX9 in maintaining cartilage function and its potential as a therapeutic target to improve graft integration and airway stability.

  • Open Access

    Tracheostomy Outcomes in Children With Bronchopulmonary Dysplasia

    by Ada Cleary Sher, Humra Shamim, Jemma Maynard, Jacob Stack, Isaac Kistler, Megan McNutt, Hajera Afreen, Amy Manning, Audrey Miller, Prasanth Pattisapu, et al.

    Objective: To quantify the tracheostomy‐related morbidity and mortality, readmissions, and airway interventions in tracheostomy‐dependent children with bronchopulmonary dysplasia (BPD).Study Design: Retrospective chart review.Setting: Tertiary care children's hospital.Methods: Infants with BPD who received tracheostomy by an otolaryngologist between January 2016 and December 2022 at a single institution were included. Surviving patients were followed to at least 2 years of age. Data were extracted from electronic medical records for patient characteristics, clinical encounters, and surgical visits.Results: There were 76 patients included in this study. The overall mortality was 30.3% (23/76) with one tracheostomy‐related death. Tracheostomy occurred at a median 56 weeks postmenstrual age (PMA). Tracheitis was the most common short‐ and long‐term adverse event (within the first postoperative week, 21%; after postoperative day 7, 81%). Other complications observed include stomal granuloma (77%), airway stenosis (69%), and accidental decannulation (38%). The 30‐day and 2‐year readmission rates were 32% and 61%, of which 61% and 76% were for tracheostomy‐related causes, respectively. The most common reason for readmission over these time periods was tracheitis. Overall decannulation rate for surviving patients was 68%, and decannulation occurred at a median 3.1 years of age. Most surviving patients returned for operative airway intervention (85%); 43% required open airway reconstruction.Conclusion: Tracheostomy‐related morbidity was low in this cohort despite a majority of patients experiencing multiple tracheostomy‐related adverse events and readmissions. Patient comorbid conditions, BPD severity, and socioeconomic status were not significantly associated with outcomes. Larger studies are needed to assess the airway interventions and outcomes in this population.


  • Microvascular Regeneration and Perfusion of Partially Decellularized Tracheal Grafts

    by Ada C. Sher, Lumei Liu, Melwan Izem, Jazmin Calyeca, Molly O. Meeker, Tendy Chiang

    Objectives: A critical barrier to successful tracheal transplantation is poor vascularization. Despite its importance, little is known about microvascular regeneration in tissue‐engineered grafts. We have demonstrated that partially decellularized tracheal grafts (PDTG) support neotissue formation including new submucosal microvasculature (CD31+). However, the perfusion of this neovasculature is unknown. In this study, we used a mouse model of tracheal replacement to measure the microvascular regeneration and perfusion of PDTG.Methods: PDTG and syngeneic tracheal grafts (STG, surgical control) (n = 5 for each group) were orthotopically transplanted into C5BL/6 J mice. We quantified vascularity of STG and PDTG samples at 1 and 3 months with conventional histology (N = 3 ~ 10/group). At 1, 3, and 6 months, animals were injected with fluorescein isothiocyanate (FITC) tomato lectin into the left ventricle. After perfusion, tracheas were fixed, harvested, mounted, stained for CD31 expression, and imaged with resonant scanning confocal microscopy. Percent CD31+, FITC area was compared between groups and endpoints compared with native trachea. Microvascular intersections were quantified using Sholl analysis.Results: Functional microvasculature was seen in both groups. Although percent vascularization (CD31) in PDTG was restored by 3 months, microvascular pattern in PDTG displayed a unique morphology compared with control. Surgery alone appeared to globally change microvascular pattern and perfusion. PDTG demonstrated equivalent perfusion to surgical control by 6 months. Sholl analysis revealed a reduction of microvessel intersectionality that persisted in PDTG and was not seen in surgical or native controls.Conclusions: PDTG exhibited microvascular regeneration. Perfusion was present in PDTG, improved, and persisted over long‐term time points.Level of Evidence: NA Laryngoscope, 135:614–621, 2025


  • Open Access

    In vivodetection of pulmonary mucociliary clearance: present challenges and future directions

    by Ada C. Sher, Mitchel R. Stacy, Susan D. Reynolds, Tendy Chiang

    Pulmonary mucociliary clearance (MCC) is an important defence mechanism of the respiratory system and clears pathogens and foreign particles from the airways. Understanding the effect of disease states, drugs, toxins and airway manipulations on MCC could be beneficial in preventing early pulmonary disease and developing new pulmonary therapeutics. This review summarises the current methods and future efforts to detect pulmonary MCCin vivo.